Legend:

• Concept Types
  • target (clinical findings)
  • classification term
  • pathway-based classification term
  • clinical findings
  • multiple types disease
  • single disease
  • disease type

• Congenital, Hereditary, and Neonatal Diseases and Abnormalities related to Glycans
  • Genetic Diseases, Inborn
    • Metabolism, Inborn Errors
      • Carbohydrate Metabolism, Inborn Errors (synthesis)
        • Hereditary disorders by systems
          • Genetic disorders of glycan synthesis (by systems, signs and symptoms)
            • Diseases
              • Nervous System Diseases
                • Neurologic Manifestations
                  • Neurobehavioral Manifestations
                    • Communication Disorders
                      • Language Disorders
                        • Speech Disorders
                          • PMM2-CDG (GDGDB) [PMM2]
                            • PMM2-CDG, infantile multisystem stage [PMM2]
                            • PMM2-CDG, late-infantile and childhood ataxia-intellectual disability stage [PMM2]
                            • PMM2-CDG, adult stable disability stage [PMM2]
                          • ALG6-CDG (GDGDB) [ALG6]
                          • ALG3-CDG (GDGDB) [ALG3]
                          • DPM1-CDG (GDGDB) [DPM1]
                          • DPAGT1-CDG (GDGDB) [DPAGT1]
                          • COG5-CDG [COG5]
                          • COG4-CDG [COG4]
                          • POMT1/POMT2-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMT1,POMT2]
                          • POMGNT1-CDG (cong. muscular dystrophy spectrum) (GDGDB) [POMGNT1]
                          • Fukuyama congenital muscular dystrophy (GDGDB) [FKTN]
                          • ST3GAL5-CDG [SIAT9]
                          • Articulation Disorders
                            • COG5-CDG [COG5]
                            • Dysarthria
                              • PMM2-CDG (GDGDB) [PMM2]
                                • PMM2-CDG, infantile multisystem stage [PMM2]
                                • PMM2-CDG, late-infantile and childhood ataxia-intellectual disability stage [PMM2]
                                • PMM2-CDG, adult stable disability stage [PMM2]
                          • DDOST-CDG [DDOST]
                          • Mental retardation, autosomal recessive 15 [MAN1B1]
                          • Hyperphosphatasia with mental retardation syndrome 1 [PIGV]
      • Lysosomal Storage Diseases (degradation)
        • Hereditary disorders by systems
          • Genetic disorders of glycan degradation (by systems, signs and symptoms)
            • Diseases
              • Nervous System Diseases
                • Neurologic Manifestations
                  • Neurobehavioral Manifestations
                    • Communication Disorders
                      • Language Disorders
                        • Speech Disorders
                          • Aspartylglucosaminuria (GDGDB) [AGA]
                          • Alpha-mannosidosis (GDGDB) [MAN2B1]
                          • Beta-mannosidosis (GDGDB) [MANBA]
                          • Mucolipidosis II (alpha/beta) (GDGDB) [GNPTAB]
                          • Sanfilippo syndrome A (GDGDB) [SGSH]
                          • Sanfilippo syndrome B (GDGDB) [NAGLU]
                          • Sanfilippo syndrome C (GDGDB) [HGSNAT]
                          • Sanfilippo syndrome D (GDGDB) [GNS]
                          • Tay-Sachs disease (GDGDB) [HEXA]
                          • Sandhoff disease (GDGDB) [HEXB]
                          • Multiple sulfatase deficiency (GDGDB) [SUMF1]
                          • Metachromatic leukodystrophy (GDGDB) [ARSA]
                          • Metachromatic leukodystrophy, due to saposin B deficiency (GDGDB) [PSAP]
                          • Niemann-Pick disease, type C1 (GDGDB) [NPC1]
                          • Niemann-Pick disease, type C2 (GDGDB) [NPC2]
                          • Farber Lipogranulomatosis (GDGDB) [ASAH1]
                            • Farber Lipogranulomatosis, type 5 [ASAH1]